Cancer

PCU College to Celebrate Spring Graduation in Burnaby

Thursday, 19 April 2012 12:07

Convocation ceremony to be held at Michael J. Fox Theatre on April 26, 2012. As graduates of PCU College, the Class of 2012 will contribute greatly to the health and wellness in Canada.

PCU College of Holistic Medicine invites friends, family and the general public to join the faculty and staff at the spring convocation ceremony at the Michael J. Fox Theatre in Burnaby on Thursday, April 26, 2012.

The ceremony marks the conclusion of several months of dedication and determination. The graduates include candidates from PCU College’s Traditional Chinese Medicine (TCM) programs, including Acupuncturist, Traditional Chinese Medicine Practitioner, Doctor of Traditional Chines...

Read more...

View / Add Comments
 

New York Mesothelioma Lawyer Applauds Advances in Gene Therapy Cited...

Thursday, 19 April 2012 10:49

mesothelioma, asbestos exposure, mesothelioma treatment, gene therapy, lawyer, attorney, personal injury, wrongful death, lawsuit, New York, Rochester, Albany, NYAttorney Joseph W. Belluck of New York’s Belluck & Fox, LLP, says a new history of gene therapy presents an optimistic outlook for the future of fighting asbestos exposure diseases. New York mesothelioma lawyer Joseph W. Belluck Advances in gene therapy have benefitted mesothelioma patients already and, we expect, they will prove even more beneficial in the future.

New York mesothelioma lawyer Joseph W. Belluck said today that a new book about gene therapy is another sign of hope for mesothelioma sufferers.

...

Read more...

View / Add Comments
 

Selexis to Present at Cell Culture Engineering XIII

Thursday, 19 April 2012 09:35

Selexis’ co-founder and scientific advisory board member, Nicolas Mermod, PhD, Professor of Biotechnology at Faculty of Biology and Medicine of the University of Lausanne, will present, “Engineering CHO Cells and Vectors for Improved Transgene Integration and Antibody Production.” Selexis Co-founder, Prof. Nicolas Mermod, PhD Engineering CHO Cells and Vectors for Improved Transgene Integration and Antibody Production

Selexis SA announced today the Company’s co-founder will present data on the Company’s core technology at the 13th Annual Cell Culture Engineering conference being held April 22 – 27, 2012 in Scottsdale, Arizona, USA.Selexis’ co-founder and scientific advisory board member, Nicolas Mermod, PhD, Professor of Biotechnology at Faculty of Biology and Medicine of the University of Lausanne, will present, “Engineering CHO Cells and Vectors for Improved Transgene Integration and Antibody Production,” on Thursday, April 26 at 3:45 PM as part of the cell line development tract.

...

Read more...

View / Add Comments
 
 

Hopecam Announces 12th Annual 5K Run/Walk on Sunday, May 6 in Reston,...

Thursday, 19 April 2012 07:07

Hopecam-logoTwo Local Children with Cancer will be Honored Guests at Charity Fundraiser

For the twelfth year in a row, Hopecam will be hosting the annual Hopecam 5K Run/Walk on Sunday, May 6, to benefit the charity’s program.Since 2003 Hopecam, Inc., a 501c(3) nonprofit charitable organization, has helped more than 225 hospitalized or homebound children cope with loneliness and isolation as they battle cancer or other life-threatening illnesses.All services are provided completely free of charge to the families and school partners.

Honored guests of this year's Hopecam 12K are Stefano Rocca and Francisco Granados.Stefano is an 8 year old boy in 2nd grade at Westbriar Elementary Scho...

Read more...

View / Add Comments
 

Top Cancer Scientists Converge to Celebrate ACGT"s 10th...

Wednesday, 18 April 2012 13:35

More than 30 of the nation's top cancer research scientists are gathering in Greenwich, Conn., this week to compare notes, collaborate, and celebrate ACGT's 10 years of innovative cancer research funding.ACGT was the funding arm of the breakthrough Leukemia clinical trial study at the University of Pennsylvania last summer that obliterated the cancer in patients. Robert Bazell, the Emmy award-winning chief science and health correspondent for NBC News, and author of the book “HER-2: The Making of Herceptin, A Revolutionary Treatment for Breast Cancer,” will be To see how far cancer gene therapy research has come in the past ten years is extremely promising.Today, we have more canc...

Read more...

View / Add Comments
 
 

Page 22 of 220